Revision as of 17:28, 31 March 2021 edit Whywhenwhohow (talk \| contribs) Autopatrolled, Extended confirmed users, Pending changes reviewers 46,450 edits update infobox ← Previous edit		Revision as of 02:08, 17 June 2021 edit undo Whywhenwhohow (talk \| contribs) Autopatrolled, Extended confirmed users, Pending changes reviewers 46,450 edits update infobox Next edit →
Line 26: \| class = [[CDK inhibitor\|Cyclin-dependent kinase (CDK) inhibitor]] \| ATCvet = \| ATC_prefix = None <!-- Scheduled to be V03AF12 in 2022 --> \| ATC_suffix = \| ATC_supplemental = Line 44: \| legal_UK_comment = \| legal_US = Rx-only \| legal_US_comment = <ref name="Cosela FDA label">{{cite web \| title=Cosela- trilaciclib injection, powder, lyophilized, for solution \| website=DailyMed \| url=https://~~www~~dailymed.~~accessdata~~nlm.~~fda~~nih.gov/~~drugsatfda_docs/label~~dailymed/drugInfo.cfm?setid=4b06922c-498d-4871-a037-84a44e6a6b6c \| access-date=17 June 2021~~/214200s000lbl.pdf~~}}</ref><ref name="FDA PR" /> \| legal_EU = \| legal_EU_comment =

Trilaciclib: Difference between revisions